Share tips 2025: this week’s top stock picks

If you’ve been keeping a close eye on share tips 2025, then don’t miss this weekly round-up of the top stocks to consider for your portfolio.

The MoneyWeek share tips 2025 guide pulls together some of the best stocks from some of the top share tipsters around.

As well as the UK financial pages, we look at publications across the pond for investors who want to diversify their holdings internationally.

MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

As the year comes to an end, we look at the best and worst performing UK stocks, and the best FTSE 250 dividend stocks for high yields.

Investors will undoubtedly use the final few weeks of 2025 to gear their portfolio up for the new year – we look at where to invest in 2026. If you prefer to stick to equities, we take a look at which sectors and regions have the best prospects for 2026.

This list is updated weekly.

Share tips 2025: top picks of the week

Five to buy

1. Jet2 (LSE: JET2)
Investors’ Chronicle
“Nothing beats a Jet2 holiday” is a slogan that rings true for the package-holiday provider. Interim revenue increased on the back of a record number of passengers, while earnings grew. The carrier raised the interim dividend and announced a £100 million buyback programme. It plans to take delivery of 132 aircraft from Airbus over the next decade and launch a new base at Gatwick next year. The stock is “attractive” thanks to Jet2’s healthy cash position and solid fundamentals. 1,406p

2. GB Group (LSE: GBG)
Investors’ Chronicle
The fraud-protection specialist is shifting its business model from pay-as-you-go to multi-year, subscription-style contracts to stabilise revenue, improve retention and rejuvenate the Americas division. The firm recently signed eight renewal contracts. Despite “modest” top-line growth, adjusted operating profit rose 4.6% to £30 million, and margins improved thanks to cost controls. The valuation looks “undemanding” given the potential return to growth in the Americas, steadier revenues, and efficiencies from becoming a global platform. 251p

3. Bristol Myers Squibb (NYSE: BMY)
Barron’s
The pharma giant’s stock has slipped 40% in three years thanks to lower sales of its flagship products, a result of patent expirations. Still, a new generation of treatments, such as oncology drug Breyanzi, which made over $1 billion in sales this year, and a promising antipsychotic, Cobenfy, bode well long term. Third-quarter total sales beat expectations, and operating cash flow hit a record. On a yield of 5.4% the stock is a “good bet”. $49

One to sell

Asos (LSE: ASC)
Investors' Chronicle
Online fashion retailer Asos posted lower interim revenue across all regions owing to lacklustre consumer confidence. Asos’s progress in transitioning away from low-price, high-volume “fast-fashion” in favour of a more disciplined pricing model to differentiate the company from rival Shein has been “mixed”. Its reported pre-tax loss narrowed, adjusted earnings rose and liquidity was bolstered after a loan was refinanced, but active online users fell 14%. Asos’s guidance also “looks unconvincing” amid an uncertain macroeconomic backdrop. The stock is at five-year lows, but there is “minimal incentive to buy the dip”, and “we remain sellers”. 245p

The rest...

1. Dominion Energy (NYSE: D)
Barron’s
Dominion Energy’s stock offers investors a buying opportunity. The US utility is set to benefit from two major investment initiatives – building more plants to power data centres and its Coastal Virginia Offshore Wind (CVOW) project to power homes. The Trump administration’s threat to end offshore wind projects is a challenge, but legal rulings suggest it is unlikely without a compelling rationale. CVOW is expected to be completed by the end of 2026, and both projects should bolster earnings. The share price could eclipse $70 next year. Buy ($63).

2. Mulberry (LSE: MUL)
Investors’ Chronicle
Mulberry’s interim pre-tax loss narrowed thanks to better management of costs, a shift towards profitable locations and stable gross profits. The luxury leather-goods company saw growth in key full-price stores in Britain, Europe and the US, while pricing discipline improved the gross margin, helping offset lower sales in the Asia-Pacific region. Still, like-for-like sales declined. Christmas trading will be key to Mulberry’s second half, and investors need to see evidence that efforts to reinvigorate the brand are translating into sales. The stock is “cheap for a reason”. Hold (93p).

This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.